| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.002 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.002 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.008 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.008 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.009 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
| mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
| mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |